Recombinant TNFRSF4 (Ivuxolimab Biosimilar) antibody
The Human Monoclonal anti-TNFRSF4 (Ivuxolimab Biosimilar) antibody is suitable to detect TNFRSF4 (Ivuxolimab Biosimilar) in samples from Human.
Catalog No. ABIN7597762
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant TNFRSF4 (Ivuxolimab Biosimilar) antibody (ABIN7597762)
Target
TNFRSF4 (Ivuxolimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This TNFRSF4 (Ivuxolimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Ivuxolimab Biosimilar Antibody
-
Specificity
- ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG2 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- TNFRSF4 (Ivuxolimab Biosimilar)
-
Alternative Name
- Ivuxolimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134
-
UniProt
- P43489
-
CAS-No
- 2225940-98-5
Target
-
You are here:
